Citigroup Inc. Acquires 2,330,898 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Citigroup Inc. significantly increased its stake in Acadia Healthcare by 5,144.2%, acquiring 2,330,898 shares, bringing its total ownership to approximately 2.58% valued at $72 million.
• Acadia Healthcare's stock recently traded at $19.24, with a 52-week range from a low of $17.13 to a high of $82.40, and a market capitalization of $1.78 billion.
• Analysts have mixed views on Acadia Healthcare, with several lowering their price targets, but consensus remains a "Moderate Buy" rating with a target of $44.75.

Citigroup Inc. boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 5,144.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,376,209 shares of the company's stock after buying an additional 2,330,898 shares during the quarter. Citigroup Inc. owned approximately 2.58% of Acadia Healthcare worth $72,047,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Treasurer of the State of North Carolina raised its stake in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after purchasing an additional 250 shares during the period. Coldstream Capital Management Inc. raised its stake in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock valued at $257,000 after purchasing an additional 303 shares during the period. Covestor Ltd raised its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock valued at $202,000 after purchasing an additional 622 shares during the period. Finally, LPL Financial LLC raised its stake in shares of Acadia Healthcare by 1.2% in the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company's stock valued at $1,651,000 after purchasing an additional 697 shares during the period.

Acadia Healthcare Price Performance

Shares of ACHC stock traded up $0.44 during trading on Wednesday, hitting $20.77. The company had a trading volume of 2,938,920 shares, compared to its average volume of 2,202,143. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market capitalization of $1.92 billion, a P/E ratio of 13.76, a price-to-earnings-growth ratio of 3.71 and a beta of 0.88. The stock's 50-day moving average price is $22.08 and its 200 day moving average price is $27.42. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The business had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same period in the previous year, the company posted $0.91 earnings per share. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ACHC has been the topic of several recent research reports. UBS Group dropped their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. Royal Bank Of Canada set a $28.00 price target on Acadia Healthcare and gave the stock an "outperform" rating in a research report on Wednesday. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Guggenheim decreased their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Finally, Mizuho decreased their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $43.25.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.